N/A Completed N=98 Screening

Screening, Brief Intervention, and Referral to Treatment in Primary Care

Type 2 Diabetes Mellitus · Substance-Related Disorders

Source: ClinicalTrials.gov NCT01966432 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2017

Primary outcomePrimary: Drug Use Status and Frequency — 2.00; 0.03; 0.02; 0.60 units on a scale

Summary

This add-on study of providing tobacco, alcohol and other drug screening, brief intervention and referral for treatment to a primary care high risk diabetic population leverages the existing research resources of a funded parent project "Duke University CMS Innovation Award Southeastern Diabetes initiative (PI: Robert M. Califf, MD)" to explore the feasibility of implementing Screening for substance use, Brief Intervention, and Referral to Treatment services in Primary Care (SBIRT-PC) and to examine the effects of substance use status on diabetes health care outcomes. This pilot study also examines the feasibility of the CTN's common data element algorithms of SBIRT for illicit and nonmedical drug use in the primary care setting.

Outcome Measures

Outcome	Result	p-value
PRIMARY Drug Use Status and Frequency	2.00; 0.03; 0.02; 0.60; 0.00; 0.00	—
PRIMARY Cigarette Smoking Status and Nicotine Dependence	1.50; 2.91; 0.00; 1.60; 2.78; 0.00	—
PRIMARY Alcohol Use Status	1.60; 0.76; 0.00; 0.00; 0.44; 0.00	—
PRIMARY Percentage of Participants Who Reported Substance Use at 6 Month	30.0; 0.0; 0.0; 0.0; 0.0; 0.0	—
PRIMARY Treatment for Drug Use or Alcohol	20.0; 0.0; 0.0; 20.0; 0.0; 0.0	—

Eligibility Criteria

Inclusion Criteria

Adults ≥ 18 years
Diagnosis of Type 2 diabetes
Reside in Durham County, NC, or the neighboring areas and receive the majority of their healthcare in the county
Referral from the primary care clinician or patient's medical home if one has been designated
Have capacity to make decisions

Exclusion Criteria

Lack capacity to make decisions and do not have a surrogate with authority to make health care decisions.
Have a terminal illness with a life expectancy of 6 months or less
Diagnosis of Type 1 diabetes or gestational diabetes
Currently pregnant
Unable to comply with study requirement

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01966432). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.